Switch View
© PR Newswire
10.09.2025
ISIN: CH1384053976
NLS Pharmaceutics AG
NLSP
LISTED
NASDAQ
Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger
News Preview
ZURICH and NESS ZIONA, Israel, Sept. 10, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP)(Nasdaq: NLSPW) ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system ("CNS") disorders, and Kadimastem Ltd. (TASE: KDST) ("Kadimastem"), an advanced clinical-stage cell therapy company progressing treatments fo...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US1255091092
Cigna Group (The)
CI
LISTED
NYSE
The Cigna Group Announces Appearance at the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
BLOOMFIELD, Conn., Sept. 10, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced that Brian Evanko, President and COO of The Cigna Group, and Ann Dennison, EVP and CFO of the Cigna Group will present at the Morgan Stanley 23rd Annual Global Healthcare Conference today, September 10, 2025, in New York, NY....
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: CA29668H1047
Essa Pharma, Inc.
EPIX
LISTED
NASDAQ
Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025
News Preview
Adjournment to provide time for continued discussions regarding possible revised financial terms of transaction with XenoTherapeutics
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 10, 2025 /CNW/ -- ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX) today announced that the Board of Directors of the Company has approved an adjournme...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
10.09.2025
ISIN: US84757T1051
Spectral AI, Inc.
MDAI
LISTED
NASDAQ
DeepView® System highlighted at the European Burns Association Congress
News Preview
DALLAS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its prominent role at the European Burns Association (EBA) conference, held from Septem...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
10.09.2025
ISIN: GB00BMVP7Y09
Royalty Pharma PLC
RPRX
LISTED
NASDAQ
Royalty Pharma Announces Release of Deloitte’s Report on the Biopharma Royalty Market
News Preview
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the release of a biopharma royalty market study conducted by Deloitte. The report, titled "Role of Royalties in Funding Biopharma Innovation," is the first of its kind and offers a comprehensive analysis of the current dynamics, growth drivers and outlo...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US68401U2042
OptimizeRx Corp
OPRX
LISTED
NASDAQ
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
News Preview
WALTHAM, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the 9th Annual Lake Street Capital Best Ideas G...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US88322Q1085
TG Therapeutics Inc
TGTX
LISTED
NASDAQ
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
News Preview
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), at the 2025 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual meeti...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Game On: Secure Your Spot at the National Mall of Pickleball and Cheer on Top Duos From Across the Country
News Preview
From September 19-21, the heart of Washington, D.C. will transform into an open-air pickleball playground for the third National Mall of Pickleball. Hosted by the Trust for the National Mall, Humana (NYSE: HUM), and the Humana Foundation, the free, three-day event brings players, fans, and community organizations together to enjoy clinics, competi...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US2210061097
CorVel Corp
CRVL
LISTED
NASDAQ
Three CorVel Partners Recognized as 2025 Theo Award Winners for Excellence in Workers’ Compensation
News Preview
Companies recognized for innovative approaches to biopsychosocial care, disaster response, and workplace safety Companies recognized for innovative approaches to biopsychosocial care, disaster response, and workplace safety...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US75955J4022
Relmada Therapeutics Inc
RLMD
LISTED
NASDAQ
Relmada Issues Mid-Year CEO Letter to Shareholders
News Preview
CORAL GABLES, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology-related and central nervous system indications, today issued a Letter to Shareholders from Sergio Traversa, Chief Executive Officer....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US89455T1097
Treace Medical Concepts Inc
TMCI
LISTED
NASDAQ
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting
News Preview
PONTE VERDE, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will highlight new product innovations and present new interim data for...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US45783C2008
Instil Bio Inc
TIL
LISTED
NASDAQ
Instil Bio Announces ImmuneOnco’s Presentation of ‘2510 Monotherapy Data in Patients with 2L+ Squamous NSCLC at the 2025 World Conference on Lung Cancer (WCLC)
News Preview
ORR of 35% in previously treated squamous NSCLC patients with responses across PD-L1 TPS scores...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
10.09.2025
ISIN: US68752L1008
OrthoPediatrics Corp
KIDS
LISTED
NASDAQ
OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System
News Preview
WARSAW, Ind., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the completion of the first U.S. surgical procedures with the VerteGlide Spinal Growth Guidance System (“VerteGlide”), used to tr...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US69353Y1038
PMV Pharmaceuticals Inc
PMVP
LISTED
NASDAQ
PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
News Preview
PRINCETON, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced interim data from the Phase 2 pivotal portion of the PYNNACLE clinical trial....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: CA74764Y2050
Quantum Biopharma Ltd
QNTM
LISTED
NASDAQ
Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target
News Preview
This was unpaid research with no consideration given This was unpaid research with no consideration given...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US45254E1073
Immuneering Corp
IMRX
LISTED
NASDAQ
Immuneering to Announce Updated Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on September 25
News Preview
Immuneering to Announce Updated Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Septe...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US7867001049
Sagimet Biosciences Inc
SGMT
LISTED
NASDAQ
Sagimet Biosciences Announces Upcoming Presentations at 9th Annual MASH Drug Development Summit
News Preview
SAN MATEO, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that the Company will give two oral presentations and participate in a drug development panel at t...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US13463J1016
CAMP4 Therapeutics Corp
CAMP
LISTED
NASDAQ
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
News Preview
Oversubscribed Financing led by Coastlands Capital with participation from new and existing investors...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.09.2025
ISIN: US36257K2087
Marijuana Inc.
MAJI
LISTED
OTC
Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets
News Preview
ORLANDO, FL / ACCESS Newswire / September 10, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company and innovator in exosome-based therapies, today announced a key strategic milestone towards expanding its commercial footprint and building significant shareholder value. The company has filed a new Provisional Patent (#63/8...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US09075P1057
BioXcel Therapeutics, Inc.
BTAI
LISTED
NASDAQ
BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia
News Preview
BXCL501 demonstrated a significant mean reduction in mCGI-S score from baseline compared to placebo at 2 hours across 2,433 treated episodes (p<.05)...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: FR0010331421
Innate Pharma SA
IPH
LISTED
EURONEXT
Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update
News Preview
Regulatory News:
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Wednesday, September 17, 2025, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first half of 2025.
Participants during the call will be:
Jonathan Di...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.09.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
MDCE Subsidiaries Generate Over $1 Million in Revenue Before Close of Q3, Paving Way for Debt-Free Growth and AI Healthcare Advancements
News Preview
Infinite Auctions' Blockbuster LeBron James Finals jersey sale and Real Game Used's authentication revenues strengthen MDCE's balance sheet and support AI-powered healthcare application development. MESA, ARIZONA / ACCESS Newswire / September 10, 2025 / Medical Care Technologies, Inc. (OTC PINK:MDCE) (www.medicalcaretechnologies.com), an emerging i...
Themefolio
Profiler
Peergroup
© EQS Newswire
10.09.2025
ISIN: CH0012627250
HBM Healthcare Investments AG
HBMN
LISTED
SIX
HBM Portfolio Company Swixx BioPharma and Lundbeck Sign Multi-Regional CNS Partnership
News Preview
HBM Healthcare Investments AG
/ Key word(s): Partnership
HBM Portfolio Company Swixx BioPharma and Lundbeck Sign Multi-Regional CNS Partnership
10.09.2025 / 08:35 CET/CEST
HBM Healthcare Investments, a leading investor in global healthcare companies, announces that its portfolio company Swixx BioPharma, and its affili......
Themefolio
Profiler
Peergroup
© EQS Newswire
10.09.2025
ISIN: CH0012627250
HBM Healthcare Investments AG
HBMN
LISTED
SIX
HBM-Portfoliounternehmen Swixx BioPharma und Lundbeck unterzeichnen multiregionale Partnerschaft im Bereich ZNS
News Preview
HBM Healthcare Investments AG
/ Schlagwort(e): Partnerschaft
HBM-Portfoliounternehmen Swixx BioPharma und Lundbeck unterzeichnen multiregionale Partnerschaft im Bereich ZNS
10.09.2025 / 08:35 CET/CEST
HBM Healthcare Investments, ein führender Investor in globale Gesundheitsunternehmen, gibt bekannt, dass sein Portfoli......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.09.2025
ISIN: US2498451085
Dermata Therapeutics Inc
DRMA
LISTED
NASDAQ
Dermata Therapeutics Announces Strategic Pivot to Over-the-Counter Skin Care Treatments
News Preview
SAN DIEGO, CA / ACCESS Newswire / September 10, 2025 / Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata" or the "Company"), a science-driven leader in dermatologic solutions, today announced a bold strategic pivot to prioritize the development and distribution of over-the-counter (OTC) pharmaceutical dermatology...
Themefolio
Profiler
Peergroup
© EQS Newswire
10.09.2025
ISIN: CH0210362643
BioVersys AG
BIOV
LISTED
XWSX
Bioversys reports corporate highlights and key financials for the first half 2025
News Preview
Ad hoc announcement pursuant to Art. 53 LR
Basel, Switzerland. September 10, 2025, 7am CEST
BV100: successful end of Phase 2 meeting with US FDA following Positive Phase 2 read-out in Ventilator-Associated Bacterial Pneumonia (VABP); Phase 3 on track to initiate in 2025; Formulation patent granted in China, extending BV100 ......
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: CH1335392721
Galderma Group AG
GALD
LISTED
XWSX
Galderma Launches Alastin® in China, Supporting the Skin’s Natural Regenerative Abilities in a Rapidly Expanding Market
News Preview
Galderma (SIX: GALD) today announced the launch of four core Alastin® products in China, marking the premium medical skincare brand’s debut in one of the world’s fastest growing aesthetic skincare markets.6-8 This is the first launch to feature Alastin by Galderma’s new re-energized, premium look and feel, a bold evolution that reflects its leader...
Themefolio
Profiler
Peergroup
© EQS Newswire
10.09.2025
ISIN: CH0360674466
Galenica AG
GALE
LISTED
SIX
Acquisition of Labor Team completed
News Preview
Galenica AG
/ Key word(s): Takeover
Launch of Galenica Diagnostics: Acquisition of Labor Team completed 10.09.2025 / 06:45 CET/CEST
Press release
Labor Team will become part of the Galenica network once the acquisition is complete.
The fourth-largest private laboratory in Switzerland will continue to operate under the Labor T......
Themefolio
Profiler
Peergroup
© EQS Newswire
10.09.2025
ISIN: CH0360674466
Galenica AG
GALE
LISTED
SIX
Übernahme von Labor Team abgeschlossen
News Preview
Galenica AG
/ Schlagwort(e): Firmenübernahme
Start von Galenica Diagnostics: Übernahme von Labor Team abgeschlossen 10.09.2025 / 06:45 CET/CEST
Medienmitteilung
Labor Team wird mit dem Abschluss der Übernahme Teil des Galenica-Netzwerks.
Das viertgrösste Schweizer Privatlabor tritt in der neuen Geschäftseinheit Galenica Diagn......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.09.2025
ISIN: CA98980M1095
Zomedica Corporation
ZOM
LISTED
XASE
Zomedica and UXR Announce Expanded Distribution Agreement in Canada
News Preview
Agreement strengthens Canadian veterinarians' access to Zomedica's advanced therapeutic and monitoring solutions ANN ARBOR, MI / ACCESS Newswire / September 10, 2025 / Zomedica Corp. (OTCQB:ZOMDF), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, announced today that it has exp...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US03237H1014
Amylyx Pharmaceuticals Inc
AMLX
LISTED
NASDAQ
Amylyx Pharmaceuticals Announces Pricing of $175 Million Underwritten Public Offering of Common Stock
News Preview
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the pricing of an underwritten public offering of 17,500,000 shares of its common stock at a public offering price of $10.00 per share. All of the shares of common stock are being offered by Amylyx. In addition, Amylyx has granted the underwriters a 30-day opti...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US02043Q1076
Alnylam Pharmaceuticals Inc
ALNY
LISTED
NASDAQ
Alnylam Announces Pricing of Upsized Offering of $575 Million Convertible Senior Notes
News Preview
Alnylam Pharmaceuticals, Inc. (“Alnylam”) (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today the pricing of its previously announced private offering of $575 million aggregate principal amount of 0.00% convertible senior notes due 2028 (the “notes”) to persons reasonably believed to be qualified institutional buyers pursuant to...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes
News Preview
Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes ...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk to streamline operations and reinvest for growth
News Preview
Bagsværd, Denmark, 10 September 2025 – Novo Nordisk today announced a company-wide transformation to simplify its organisation, improve the speed of decision-making, and reallocate resources towards the company’s growth opportunities in diabetes and obesity. As part of the transformation, Novo Nordisk intends to reduce the global workforce by appro...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: KYG0146B1032
Akeso, Inc.
9926
LISTED
HKSE
Cadonilimab(PD-1/CTLA-4) plus Pulocimab (VEGFR-2) Combination Therapy Shows Promising Results in IO-Resistant Non-Small Cell Lung Cancer in Oral Presentation at the 2025 WCLC
News Preview
HONG KONG, Sept. 9, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) announced that data from a Phase Ib/II clinical study evaluating the combination of cadonilimab and pulocimab (an anti-VEGFR-2 antibody) in patients with immunotherapy (IO)-resistant NSCLC were presented in a Mini Oral session at the 2025 World Conference on Lung Cancer (WCLC). This ma...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Did You Lose Money in Nutex Health Inc.? If you Lost Money in Nutex Health Inc., Contact Robbins LLP for Information About the NUTX Securities Class Action Lawsuit
News Preview
SAN DIEGO, Sept. 9, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Nutex Health Inc. (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025. Nutex is a physician-led, healthcare services and operations company that began publi...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RXST INVESTOR DEADLINE: RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
News Preview
SAN DIEGO, Sept. 9, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the RxSight class action lawsuit – captioned Makaveev v. RxSight, Inc., No. 25-cv-01596 (C.D. Cal.) – seeks to represent purchasers or acquirers of RxSight, Inc. (NASDAQ: RXST) securities and charges RxSight as well as certain of RxSight's...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
Align Technology Hosts the 2025 Invisalign® GP Summit, Its Premier Education Event for Dental Practices to Explore the Latest Invisalign® System, iTero™ Scanner, and Align™ Digital Platform Innovations
News Preview
Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights from the 2025 Invisalign® GP Summit, Align’s pre...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US2528281080
Dianthus Therapeutics Inc
DNTH
LISTED
NASDAQ
Dianthus Therapeutics, Inc. Announces Pricing of Upsized $251 Million Underwritten Public Offering
News Preview
NEW YORK and WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases (“Dianthus” or the “Company”), today announced the pricing of its previously announced...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
ISIN: US75383L1026
Rapport Therapeutics Inc.
RAPP
LISTED
NASDAQ
Rapport Announces Pricing of Public Offering of Common Stock
News Preview
BOSTON and SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced the pricing of an underwri...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Sept. 9, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclus...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis
News Preview
MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces it has dosed the first patient in a Phase 3 clinical trial aimed at expanding the indications for Illuccix® and Gozellix® (kits for the preparation of gallium-68 (68Ga) gozetotide injection) to inclu...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Court Approves CenterWell's Winning Bid to Acquire Assets of The Villages Health ("TVH")
News Preview
ORLANDO, Fla., Sept. 9, 2025 /PRNewswire/ -- The Villages Health ("TVH"), the trusted healthcare system for The Villages retirement community in Florida, today announced that the United States Bankruptcy Court for the Middle District of Florida (the "Court") approved a winning asset bid for CenterWell Senior Primary Care to acquire TVH's assets a...
Themefolio
Profiler
Peergroup
© PR Newswire
10.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
News Preview
SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in in the Eastern District of New York, co...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.09.2025
ISIN: CA53946V2066
Lobe Sciences Ltd.
LOBE
LISTED
CSE
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
News Preview
VANCOUVER, B.C. / ACCESS Newswire / September 9, 2025 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F) a clinical stage biopharmaceutical company focused on developing products to treat diseases with significant unmet medical needs is pleased to announce its participation in the upcoming Cluster...
Themefolio
Profiler
Peergroup
© PR Newswire
09.09.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar Named a Best Workplace for Innovators in North America by Fast Company
News Preview
Recognition highlights Waystar's impact as a technology innovator, driving breakthrough AI and automation to transform healthcare's financial experience
LEHI, Utah and LOUISVILLE, Ky., Sept. 9, 2025 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced it has been named to Fast Company's 2025 Be...
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2025
ISIN: US8064071025
Henry Schein Inc
HSIC
LISTED
NASDAQ
Henry Schein Announces $750 Million Share Repurchase Plan
News Preview
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $750 million of shares of the Company's common stock.
This program is in addition to the $500 million repurchase...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis
News Preview
MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces it has dosed the first patient in a Phase 3 clinical trial aimed at expanding the indications for Illuccix® and Gozellix® (kits for the preparation of gallium-68 (68Ga) gozetotide injection) to i...
Themefolio
Profiler
Peergroup
© Newsfile
09.09.2025
ISIN: CA78471G1000
SOL Global Investments Corp.
SOL
LISTED
CSE
SOL Global Provides Digital Assets Update
News Preview
Toronto, Ontario--(Newsfile Corp. - September 9, 2025) - SOL Global Investments Corp. (CSE: SOL) (OTCID: SOLCF) (FSE: 9SB) ("SOL Global" or the "Company") is pleased to provide an update regarding the Company's digital asset holdings.The Company confirms that all 29,858 Solana tokens in custody, as of the close of business on September 8, 2025, are...
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2025
ISIN: US92214X1063
Varex Imaging Corp
VREX
LISTED
NASDAQ
Varex to Present at the Sidoti Small Cap Virtual Conference
News Preview
Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Sidoti Small Cap Virtual Conference.
Management will be presenting on Wednesday, September 17, 2025 at 3:15pm ET. The webcast can be accessed here or on Varex’s website at www.vareximaging.com/news.
About Varex
Varex Imaging Corporation is...
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. (SVRA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SAVARA (SVRA), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS...
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Securities Fraud Investigation Into Savara Inc. (SVRA) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON SAVARA (SVRA),...
Themefolio
Profiler
Peergroup
© Newsfile
09.09.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
CSE Bulletin: Consolidation - BioVaxys Technology Corp. (BIOV)
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 9 septembre/September 2025) - BioVaxys Technology Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares. As a result, the number of outstanding shares will be r...
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Securities Fraud Investigation Into Savara Inc. (SVRA) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON SAVARA (SVRA), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS...
Themefolio
Profiler
Peergroup
© PR Newswire
09.09.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated
News Preview
First and only drug releasing system to provide extended local delivery of a cancer medication into the bladder, with 82 percent of patients achieving complete response without the need for reinduction1
Potential practice-changing treatment for certain patients with BCG-unresponsive non-muscle invasive bladder cancer who have limited options bef...
Themefolio
Profiler
Peergroup
© PR Newswire
09.09.2025
ISIN: US2358511028
Danaher Corp
DHR
LISTED
NYSE
Danaher Announces Quarterly Dividend
News Preview
WASHINGTON, Sept. 9, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on October 31, 2025 to holders of record on September 26, 2025.
ABOUT DANAHERDanaher is a leading global life sciences and diagnostics...
Themefolio
Profiler
Peergroup
© PR Newswire
09.09.2025
ISIN: US1124631045
Brookdale Senior Living Inc
BKD
LISTED
NYSE
Brookdale Reports August 2025 Occupancy
News Preview
NASHVILLE, Tenn., Sept. 9, 2025 /PRNewswire/ --Brookdale Senior Living Inc. (NYSE: BKD) reported today its consolidated occupancy for August 2025.
August 2025 Observations:
August consolidated weighted average occupancy grew 290 basis points year-over-year and 70 basis points sequentially to 81.8%.Third quarter-to-date consolidated weighted ave...
Themefolio
Profiler
Peergroup
© PR Newswire
09.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Replimune (REPL) Faces Investor Lawsuit After FDA Blocks Cancer Drug Approval - Hagens Berman
News Preview
REPL Investors with Losses Encouraged to Contact the Firm
SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ -- Replimune Group Inc. (NASDAQ: REPL) is under fire from investors following a dramatic regulatory setback that sent its stock into freefall. A newly filed securities class action accuses the biotech firm and its leadership of concealing critical...
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2025
ISIN: US2074101013
Conmed Corp
CNMD
LISTED
NYSE
CONMED Corporation Adds Kim Kelderman to its Board of Directors
News Preview
CONMED Corporation (NYSE: CNMD) today announced that Kim Kelderman will be joining its Board of Directors effective September 8, 2025.
“My fellow directors and I are delighted to welcome Kim to the board,” said LaVerne Council, Chair of CONMED’s Board of Directors. “Kim brings extensive global leadership experience across life sciences businesse...
Themefolio
Profiler
Peergroup
© PR Newswire
09.09.2025
ISIN: US54948X1090
Lucid Diagnostics Inc.
LUCD
LISTED
NASDAQ
Lucid Diagnostics Announces Proposed Public Offering of Common Stock
News Preview
NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced its intention to offer shares of common stock through an underwritten public offering. The Company also plans to...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
